Although paclitaxel is known to cause mild skin toxicity, it may induce severe HFS requiring drug withdrawal. Patients with high disease burden might receive prolonged paclitaxel chemotherapy. Hence, a grade 2 toxicity would better indicate withdrawal of paclitaxel instead of suspension and rechallenge, to prevent such severe HFS requiring long-time recovery.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813109 | PMC |
| http://dx.doi.org/10.1002/ccr3.3573 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
From spasms to smiles: how facial recognition and tracking can quantify hemifacial spasm severity and predict treatment outcomes.
Acta Neurochir (Wien)
January 2025
Department of Neurosurgery, University Medicine Greifswald, Greifswald, Germany.
Purpose: Currently available grading and classification systems for hemifacial spasm either rely on subjective assessments or are excessively intricate. Here, we make use of facial recognition and facial tracking technologies towards accurately grouping patients according to severity and characteristics of the spasms.
Methods: A retrospective review of our prospectively maintained preoperative videos database for hemifacial spasm was done.
Probiotics prevent pegylated liposomal doxorubicin-associated hand-foot syndrome and oral mucositis of breast cancer patients following surgery and chemotherapy:a randomized placebo-controlled trial.
Int J Surg
December 2024
Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Background: Hand-foot syndrome (HFS) and oral mucositis (OM) are common adverse events during cancer chemotherapy and can significantly decrease patients' quality of life and chemotherapy adaptation, however, prevention strategies of these complications yet to be established.
Methods: Patients with stage I-III breast cancer, who had surgery and needed pegylated liposomal doxorubicin (PLD)-based adjuvant chemotherapy were screened, recruited and randomly assigned to receive either probiotics or placebo (three capsules, twice/day) treatment during the course of chemotherapy from Nov. 2019 to Aug.
Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999-2018.
BMC Gastroenterol
December 2024
College of Medicine, Huanghe University of Science and Technology, 666 Zijingshan South Road, Zhengzhou, Henan, 450061, China.
Background: Several studies have demonstrated that systemic immune inflammation index (SII) has a positive relationship with hepatic steatosis. However, it is lack of system evidence for the correlation between SII and hepatic fibrosis. The objective of this study was to evaluate the relationships between SII and hepatic steatosis or hepatic fibrosis.
View Article and Find Full Text PDFRobot-assisted stylomastoid foramen puncture and radiofrequency ablation for hemifacial spasm treatment: clinical outcomes and technique assessment.
Neurosurg Focus
December 2024
1Clinical Neuroscience Center, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai; and.
Objective: Stylomastoid foramen (SMF) puncture with radiofrequency ablation (RFA) is a minimally invasive therapy for hemifacial spasm (HFS) with notable therapeutic outcomes. Conventionally, this procedure is performed under CT guidance. The present study highlights the authors' preliminary clinical experience with robot-assisted SMF puncture in 7 patients with HFS using a neurosurgical robot.
View Article and Find Full Text PDFUsefulness of Hospital and Community Pharmacists Collaborating to Manage Capecitabine-induced Severe Hand-foot Syndrome in Patients with Breast Cancer.
Asian Pac J Cancer Prev
November 2024
Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
Background: The management of capecitabine-related hand-foot syndrome (HFS) is critical to avoid progression of the syndrome through early detection and early response; management of HFS involves joint medication management by physicians and pharmacists (hospital and community pharmacists). This study aimed to evaluate the effectiveness of collaborative medication management in cancer patients with HFS by comparing its effectiveness with the traditional response using monitoring reports from community pharmacists.
Patients And Methods: Medical records of 120 breast cancer patients who received capecitabine therapy between September 2017 and August 2023 were retrospectively reviewed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!